The future of Online Pharmacies

May 28, 2009

According to an article in the magazine «Time», Americans spend on visits to the doctor more than any other in another developed country. For example, compare the price for Lipitor, the drug, reducing the number of cholesterol. To write a prescription for it in the United States is required to spend from $272 to $308. While in Canada the same product can be purchased ranging from $159 to $199. The difference is essential. Therefore, when many Americans are turning their attention on the Internet hoping to find cheaper drugs, online pharmacy market is very attractive.

For example, one of the leading companies selling cosmetics and medicines, Drugstore.com, Inc., And was placed on its website a list of 50 best web sites that sell drugs. On its website the company publishes comparative information on prices and host somewhere else, which shows that their prices are, on average, lower than, for example, the national chain pharmacies. But consumers increasingly prefer to turn to online pharmacies in search of lower prices that we offer in our store.

In January 2004, established by means of a website polenta Governor began to act, allowing the citizens of Minnesota to reduce their spending on drugs by ordering them directly from Canada. Minnesota - the first state to establish such a website that may violate federal law FFDCA. The Secretary-General of the State of Rhode Island also called on the state leadership to join those cities and states are planning to buy drugs from Canada despite a federal ban on their importation. City of Springfield, Massachusetts, already imports Canadian drugs, along with New Hampshire and Illinois, which belong to a group of states and municipalities developing various programs to purchase drugs from Canada. Boston Mayor Thomas Menin, the city plans to allow employees and retirees to buy drugs already this year, despite the federal government ban on the importation of medications requiring a prescription. FDA also emphasizes that the purchase of medicines in Canada can be risky, because the federal authorities could not guarantee their security nor, nor - more effective.

Today’s laws of the United States and the administration’s policies to control the use of the drug law prohibits the importation of drug products from foreign manufacturers, especially without a license.
However, as citizens seek to take advantage of significant savings and convenience that are associated with the purchase of drugs via the Internet, the popularity of this business to grow. Lobby will continue its efforts to encourage the Government to take a more progressive position on this issue than a simple prohibition policies.

Extended research of new drug against diabetes

May 22, 2009

Research of drug used in diabetes, saxagliptin was extended from 30 April until 30 July decision of the control of food and medicines.
Company, which manufactures the drug, Bristol Myers Squibb and AstraZeneka itself requested the extension of the study.
Earlier this month, medical experts have determined that the product does not exceed regulatory risk of cardiovascular disease.
Saksagliptin this type of drug, called DPP-4 inhibitor, is aimed at raising the so-called hormone inkretina, which reduces the level of glucose in the blood.
The drug DPP-4 is currently on the market in the United States produces only pharmaceutical company Merck & Co. and Yanuviya.
At the end of last year, the Office for the control of food and medicines reported that pharmaceutical companies would have to conduct more rigorous clinical trials for drugs used in diabetes type 2, in order to better assess the risks of heart attack and stroke.

Methadone can be used to treat leukemia

May 8, 2009

Synthetic opioid methadone, used in several countries for treatment of severe drug addiction, is effective in some forms of leukemia. German scientists have found that methadone therapy stimulates the death of tumor cells, including those resistant to chemotherapy and radiation.

The basis of methadone treatment of drug addiction is the ability of the substance in contact with the opioid receptors of the brain. Recent studies have shown that opioid receptors also exist on the surface of certain cancer cells, in particular, LEUKEMIC CELLS.

Scientists from the University of Ulm (University Ulm) tested the effect of different doses of methadone on the T-lymphoblastic leukemia cell lines, human myeloid leukemia, as well as normal blood cells. It was found that the use of high doses of methadone (30 mikromol per liter) leads to the destruction of virtually all tumor cells - including those resistant to conventional chemotherapy - within 48 hours. At the same time, healthy blood cells are not affected, said study leader Claudia Friesen (Claudia Friesen).

According to researchers, the effect of methadone associated with exposure to the mitochondria LEUKEMIC cells and activation of specific enzymes - caspases. These enzymes stimulate apoptosis - programmed cell death, said Friesen.

The researchers noted that, initially, in the experiments used the high single dose of methadone, a potentially toxic to humans. However, subsequent experiments have shown that daily use of methadone in the lower doses may have a similar effect. At present, scientists plan to begin trials of methadone therapy in animals, Friesen added.

Brazilian soccer team will not be able to play without the “Viagra”

May 8, 2009

Scandalous news appeared in the world of Brazilian soccer: one of the professional clubs will improve your players’ stamina pill “Viagra”.

This recognition is made by medical experts of the club, who conducted a study and found that the famous blue pill in addition to its normal function of blood vessels expand and to better saturate the blood with oxygen. These qualities, according to head a study of doctor Alariko Eldresa may improve the ability of players that play in stadiums in the mountainous terrain.

“Viagra” accelerates blood circulation. This can improve the game of football players at high altitude. This idea I found in one unprofessional magazine, we decided to check its health by now, we need only to submit the results of the technical commission “, - said A. Eldres.

“Viagra” will be issued to players during a Libertadores Cup game (similar to the European Champions Cup), in which matches are held on the territory of Bolivia, at an altitude of more than 2,5 thousand meters. At the moment, “Viagra” is not included in the list of substances banned for use by professional athletes during the competitions.

Swine flu enrich the pharmaceutical companies

May 7, 2009

Swine flu enrich the pharmaceutical companies, analysts believe

Analysts expect growth in the shares of pharmaceutical companies on Monday morning, following statements by “Roche” and “GlaxoSmithKline”, that they may have to raise millions of doses of vaccine to protect against porcine influenza. Reported “k2kapital” with reference to the edition of “Sunday Telegraph”.

Vaccines “Tamiflu” production “Roche” and “Relenza” production “GSK” has shown its effectiveness against the virus samples of the new disease. The drugs used to protect against outbreaks of avian influenza in Asia and brought the companies make enormous profits. “Roche” has confirmed that she already has 3 million packages “Tamiflu”, ready for use by the World Health Organization.

“I think pharmaceutical companies will grow, but not for long, unless things got out of control”, - said the broker “Killik & Co” Sex Keyvanag.

Roche and AstraZeneca: competition to the treatment of lung cancer

May 3, 2009

Roche and AstraZeneca: competition to the treatment of lung cancer

Roche Holding AG is studying the effectiveness of its drug Tarceva in the treatment of lung cancer among patients with a genetic mutation. If the study shows that Tarceva effectively its competitor - Iressa production AstraZeneca Plc, this will be the next stage of the struggle for the European market.

Roche announced the start of the joint with the Spanish Group for the Study of Lung Cancer Phase III study drug Tarceva as first-line therapy for lung cancer in patients with genetic mutations in the epidermal growth factor receptor (REFR). The statement was made on the next day, after European regulators recommended the use of Iressa company AstraZeneca in the same category of patients.

Unlike Iressa Tarceva, according to the results of studies showed efficacy in all patients, regardless of the presence of mutations in REFR. However, both drugs effectively especially in tumors with mutated genes. The presence of mutations in molecules REFR occurs in 10-15% of cases of lung cancer in Europe, and approximately one-third of cases in Asia.

Iressa, which is to receive every day, has not yet been approved for use in Europe but in Asia, its sales volume in 2008 was about 250 million U.S. dollars. Tarceva, developed by OSI Pharmaceuticals Inc, was approved in Europe since 2005 for the treatment of non lung cancer.

Deutsche Bank analysts said that Iressa, perhaps, after approval in Europe will become a niche product. In their forecast, sales of Iressa in 2014 will reach 474 million U.S. dollars.